Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, paving the way for a new type of ...
Becoming the first treatment for rare genetic disorder Prader-Willi syndrome, breakthrough therapy drug DCCR (diazoxide choline) gained U.S. FDA approval as Vykat XR the evening before its March 27 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results